Details of the Drug Formulations

General Information of Drug (ID: DMVE3TK)

Drug Name
Bromocriptine Drug Info
Synonyms
Bagren; Bromergocryptine; Bromocriptin; Bromocriptina; Bromocriptinum; Bromocryptin; Bromocryptine; Bromoergocriptine; Bromoergocryptine; Ergoset; Parlodel; Bromocriptine [BAN]; Bromocriptine methanesulfonate; Parlodel Snaptabs; Alti-Bromocriptine; Apo-Bromocriptine; Bromocriptina [INN-Spanish]; Bromocriptinum [INN-Latin]; CB-154; Parlodel (TN); Bromocriptine (USAN/INN); Bromocriptine [USAN:BAN:INN]; Ergocryptine, 2-bromo-(8CI); (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman; (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman; (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman; (6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide; 2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione; 2-Bromo-alpha-ergocryptine; 2-Bromo-alpha-ergokryptin; 2-Bromo-alpha-ergokryptine; 2-Bromoergocryptine Methanesulfonate; 2-Bromoergokryptine
Indication
Disease Entry ICD 11 Status REF
Acromegaly 5A60.0 Approved [1]
Hyperprolactinaemia 5A60.1 Approved [1]
Parkinson disease 8A00.0 Approved [2]
Postencephalitic Parkinson disease Approved [1]
Therapeutic Class
Antiparkinson Agents
Cross-matching ID
PubChem CID
31101
ChEBI ID
CHEBI:3181
CAS Number
25614-03-3
TTD ID
D06YFA
VARIDT ID
DR00550
INTEDE ID
DR0233
ACDINA ID
D00079

Full List of Drug Formulations Containing This Drug

Bromocriptine 5 mg capsule
Company Formulation ID FDA Description
Avera McKennan Hospital; Mylan Pharamceuticals F02725 Anhydrous lactose; Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Maleic acid; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac; Starch, corn
Cadila Healthcare F02726 D&c red no. 28; Lactose monohydrate; Maleic acid; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Silicon dioxide; Gelatin
Zydus Pharmaceuticals F02727 Lactose monohydrate; Maleic acid; Butyl alcohol; Isopropyl alcohol; Magnesium stearate; Ammonia; Ferric oxide red; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Titanium dioxide; Water; Silicon dioxide; Alcohol; Carrageenan; Hypromellose 2910 (15 mpa.s); Shellac
Validus Pharmaceuticals F02729 Lactose; Sodium lauryl sulfate; Isopropyl alcohol; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Gelatin; Povidones; Starch, corn
Sun Pharmaceutical Industries F02730 Lactose, unspecified form; Sodium lauryl sulfate; Isopropyl alcohol; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Gelatin; Povidones; Starch, corn
Sandoz F02728 Lactose; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Silicon dioxide; Gelatin; Starch, corn
Novartis Pharmaceuticals Corporation; Validus Pharmaceuticals F02731 Lactose; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Gelatin; Starch, corn
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Formulation(s)
Bromocriptine 2.5 mg tablet
Company Formulation ID FDA Description
Validus Pharmaceuticals F02721 Lactose; Maleic acid; Isopropyl alcohol; Magnesium stearate; Silicon dioxide; Povidones; Starch, corn
Sun Pharmaceutical Industries F02722 Lactose, unspecified form; Maleic acid; Isopropyl alcohol; Magnesium stearate; Silicon dioxide; Povidones; Starch, corn
Kaiser Foundation Hospitals; Mylan Pharamceuticals; Physicians Total Care F02719 Anhydrous lactose; Sodium lauryl sulfate; Maleic acid; Magnesium stearate; Edetate disodium; Starch, corn
American Health Packaging F02723 Lactose monohydrate; Maleic acid; Magnesium stearate; Edetate disodium; Silicon dioxide; Povidone, unspecified; Starch, corn
Sandoz F02724 Lactose monohydrate; Maleic acid; Magnesium stearate; Edetate disodium; Silicon dioxide; Povidones; Starch, corn
Carilion Materials Management; Kaiser Foundation Hospitals; Paddock Laboratories, F02720 Anhydrous lactose; Maleic acid; Magnesium stearate; Silicon dioxide; Povidone k25; Starch, corn
Novartis Pharmaceuticals Corporation; Validus Pharmaceuticals F02732 Lactose; Magnesium stearate; Silicon dioxide; Povidones; Starch, corn
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Formulation(s)
Bromocriptine 0.8 mg tablet
Company Formulation ID FDA Description
Santarus F02718 Lactose, unspecified form; Magnesium stearate; Citric acid monohydrate; Silicon dioxide; Starch, corn
------------------------------------------------------------------------------------

References

1 Bromocriptine FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 35).